Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Collins

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
Journal of Medicinal Chemistry|May 13, 2009
Novel orally bioavailable gamma-secretase inhibitors with excellent in vivo activityLinda E Keown, Ian Collins, Laura C Cooper, et al.
The Journal of Biological Chemistry|September 22, 2005
Novel inhibitors of bacterial cytokinesis identified by a cell-based antibiotic screening assayNeil R Stokes, Jörg Sievers, Stephanie Barker, et al.
Journal of Medicinal Chemistry|July 4, 2009
Identification of inhibitors of checkpoint kinase 1 through template screeningThomas P Matthews, Suki Klair, Samantha Burns, et al.
Journal of Medicinal Chemistry|April 19, 2002
3-Heteroaryl-2-pyridones: benzodiazepine site ligands with functional delectivity for alpha 2/alpha 3-subtypes of human GABA(A) receptor-ion channelsIan Collins, Christopher Moyes, William B Davey, et al.
Journal of Medicinal Chemistry|April 30, 2010
Creating an antibacterial with in vivo efficacy: synthesis and characterization of potent inhibitors of the bacterial cell division protein FtsZ with improved pharmaceutical propertiesDavid J Haydon, James M Bennett, David Brown, et al.
Journal of Medicinal Chemistry|October 13, 2010
Aminopyrazine inhibitors binding to an unusual inactive conformation of the mitotic kinase Nek2: SAR and structural characterizationDaniel K Whelligan, Savade Solanki, Dawn Taylor, et al.
Journal of Medicinal Chemistry|December 29, 2010
Structure-based design of potent and selective 2-(quinazolin-2-yl)phenol inhibitors of checkpoint kinase 2John J Caldwell, Emma J Welsh, Cornelis Matijssen, et al.
Journal of Medicinal Chemistry|December 15, 2017
Demonstrating In-Cell Target Engagement Using a Pirin Protein Degradation Probe (CCT367766)Nicola E A Chessum, Swee Y Sharp, John J Caldwell, et al.
Plos One|June 19, 2013
Fragment-based screening maps inhibitor interactions in the ATP-binding site of checkpoint kinase 2M Cris Silva-Santisteban, Isaac M Westwood, Kathy Boxall, et al.
Journal of Medicinal Chemistry|February 7, 2023
Discovery of 2-(3-Benzamidopropanamido)thiazole-5-carboxylate Inhibitors of the Kinesin HSET (KIFC1) and the Development of Cellular Target Engagement ProbesFrançois Saint-Dizier, Thomas P Matthews, Aaron M Gregson, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Journal of Medicinal Chemistry|May 13, 2009
Novel orally bioavailable gamma-secretase inhibitors with excellent in vivo activityLinda E Keown, Ian Collins, Laura C Cooper, et al.
The Journal of Biological Chemistry|September 22, 2005
Novel inhibitors of bacterial cytokinesis identified by a cell-based antibiotic screening assayNeil R Stokes, Jörg Sievers, Stephanie Barker, et al.
Journal of Medicinal Chemistry|July 4, 2009
Identification of inhibitors of checkpoint kinase 1 through template screeningThomas P Matthews, Suki Klair, Samantha Burns, et al.
Journal of Medicinal Chemistry|April 19, 2002
3-Heteroaryl-2-pyridones: benzodiazepine site ligands with functional delectivity for alpha 2/alpha 3-subtypes of human GABA(A) receptor-ion channelsIan Collins, Christopher Moyes, William B Davey, et al.
Journal of Medicinal Chemistry|April 30, 2010
Creating an antibacterial with in vivo efficacy: synthesis and characterization of potent inhibitors of the bacterial cell division protein FtsZ with improved pharmaceutical propertiesDavid J Haydon, James M Bennett, David Brown, et al.
Journal of Medicinal Chemistry|October 13, 2010
Aminopyrazine inhibitors binding to an unusual inactive conformation of the mitotic kinase Nek2: SAR and structural characterizationDaniel K Whelligan, Savade Solanki, Dawn Taylor, et al.
Journal of Medicinal Chemistry|December 29, 2010
Structure-based design of potent and selective 2-(quinazolin-2-yl)phenol inhibitors of checkpoint kinase 2John J Caldwell, Emma J Welsh, Cornelis Matijssen, et al.
Journal of Medicinal Chemistry|December 15, 2017
Demonstrating In-Cell Target Engagement Using a Pirin Protein Degradation Probe (CCT367766)Nicola E A Chessum, Swee Y Sharp, John J Caldwell, et al.
Plos One|June 19, 2013
Fragment-based screening maps inhibitor interactions in the ATP-binding site of checkpoint kinase 2M Cris Silva-Santisteban, Isaac M Westwood, Kathy Boxall, et al.
Journal of Medicinal Chemistry|February 7, 2023
Discovery of 2-(3-Benzamidopropanamido)thiazole-5-carboxylate Inhibitors of the Kinesin HSET (KIFC1) and the Development of Cellular Target Engagement ProbesFrançois Saint-Dizier, Thomas P Matthews, Aaron M Gregson, et al.
Pageof 11